We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Novel Insights on COVID-19 Vaccines and Virus Evolution, AI in the Clinic, and Miniaturization of Diagnostic Platforms Explored at AACC 2021

By LabMedica International staff writers
Posted on 29 Sep 2021
Print article
Illustration
Illustration

At the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo, laboratory medicine experts presented the cutting-edge research and technology that is revolutionizing clinical testing and patient care.

From September 26-30 in Atlanta, Georgia, the meeting's 200-plus sessions delivered insights on a broad range of timely healthcare topics. Highlights of these included discussions exploring COVID-19 vaccines and virus evolution, research lessons learned from the pandemic, artificial intelligence (AI) in the clinic, clinical translation of engineered microsystems, and improvements to treatments for cystic fibrosis. Additionally, at the Clinical Lab Expo, more than 400 exhibitors displayed innovative technologies that are just coming to market in every clinical lab discipline.

COVID-19 Vaccines and Virus Evolution. SARS-CoV-2 is an RNA virus that easily mutates, and mutants that are not suppressed by the immune responses generated from prior infection or vaccination can then become dominant strains. In this plenary session, Dr. Margaret Liu, CEO of PAX Therapeutics and Chairman of the Board of the International Society for Vaccines, shed light on whether the vaccines to fight this virus need to be able to neutralize newly arising strains, or if SARS-CoV-2 vaccines need to be remade annually like the flu vaccine to try to correspond to the current clinical circulating strains.

COVID-19 Research: Lessons Learned. The COVID-19 pandemic led to enormous scientific progress in a short time, and the development of the vaccines and the understanding of the virus happened at unprecedented rates and with great success. However, the effects of the pandemic have been dramatic on the scientific workforce, on the speed with which publishing has occurred, and on the ability to build public trust in science. In this plenary session, Holden Thorp, PhD, Editor-in-Chief, Science Family of Journals, addressed the need for the scientific community to come together to face the enormous challenges posed by the need for greater trust in science in the public in the U.S. and beyond.

AI in the Clinic. In the meeting's opening keynote, Dr. Regina Barzilay, School of Engineering Distinguished Professor for AI and Health at the Massachusetts Institute of Technology, explored the fact that, by nature, many traditional clinical tasks such as risk assessment, prediction of treatment efficacy, and forecasting patient trajectory can be thought of as prediction problems. Given sufficient amounts of patient data with outcomes, a machine learning model can make predictions which often exceed human experts in accuracy. However, to make these tools more applicable in the clinical setting, there is a need to augment AI models with the ability to explain their decisions to humans, and assess their uncertainty.

Changing Lives of Patients with Cystic Fibrosis. Over the past 30 years, there has been a remarkable expansion in understanding of the genetic basis, molecular biology, and pathophysiology of cystic fibrosis resulting from loss of cystic fibrosis transmembrane regulator (CFTR) protein function. The most extraordinary accomplishment has been the international effort of patients, families, clinicians, scientists, and non-profit foundations to translate this scientific knowledge into approved therapies, known as CFTR modulators, that are transforming the lives of individuals with cystic fibrosis. This plenary session included two perspectives: that of Bonnie Ramsey, MD, Endowed Chair in Cystic Fibrosis Research at the University of Washington School of Medicine, who participated in the clinical development of this class of drugs, and that of Caley Mauch, a person living with cystic fibrosis, who described the impact of this therapy on daily life.

Miniaturization of Diagnostic Platforms. In this, the meeting's closing keynote, Dr. Wilbur A. Lam, W. Paul Bowers Research Chair and Chief Innovation Officer, Pediatric Technology Center at Emory University/Georgia Institute of Technology, discussed microsystems-based COVID-19 diagnostics and his own lab's recent advances in miniaturization of diagnostic platforms, with a focus on hematology and hemostasis/thrombosis.

"If the pandemic has shown us anything, it is laboratory medicine's capacity to adapt to changing healthcare circumstances and use the field's scientific insights to improve quality of life. This capacity is constantly growing, with cutting-edge diagnostic technologies emerging every day in areas as diverse as SARS-CoV-2, artificial intelligence, cystic fibrosis, and miniaturization," said AACC CEO Mark J. Golden.

Gold Supplier
COVID-19 Real Time RT-PCR Kit
respiraScreen 1
New
Clinical Chemistry Reagents
SEKURE Clinical Chemistry Reagents
New
Cardiovascular Disease POC Analyzer
cobas h 232 POC System
New
SARS-CoV-2 Antigen Immunofluorescence System
Watmind SARS-CoV-2 Antigen Immunofluorescence System

Print article

Channels

Molecular Diagnostics

view channel
Image: Absence of nuclear immunohistochemical staining of MSH2 protein (A) and presence of MLH1 protein (B) in urothelial cell carcinoma of the urinary bladder of a patient carrying a germline MSH2 mutation. Observe the nuclear staining in stromal cells as an internal control (Photo courtesy of Radboud University Nijmegen Medical Centre)

Simple Urine Test Detects Urothelial Cancers in Lynch Syndrome Patients

Lynch Syndrome (LS) is an inherited genetic disorder that carries a high risk of cancer. LS is caused by mutations affecting MLH1, MSH2, MSH6 or PMS2 genes. More than one in 300 people have LS but most... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test for screening, diagnosis and management of sickle cell disease and related hemoglobinopathies at the point of care (Photo courtesy of Hemex Health)

Point-of-Care Device Accurately Rapidly Diagnoses Sickle Cell Disease

Hemoglobinopathies are the most common autosomal hereditary disorders. Approximately 7% of the global population carries hemoglobin gene mutation including structural hemoglobin variants like sickle hemoglobin... Read more

Immunology

view channel
Image: The IMMULITE 2000 XPi Immunoassay System provides multiple tests on a single, easy-to-use analyzer, including the thyroid-stimulating immunoglobulin assay (Photo courtesy of Siemens Healthcare)

Immunoassays Evaluated for Thyroid-Stimulating Receptor Antibody in Graves’ Disease

Graves' disease (GD), also known as toxic diffuse goiter, is an autoimmune disease that affects the thyroid. It frequently results in and is the most common cause of hyperthyroidism and it also often results... Read more

Microbiology

view channel
Image: The sciREADER CL2 enables high quality digital colorimetric imaging of various support formats (Photo courtesy of SCIENION)

Multiplex Immunoassay Developed for Confirmation and Typing of HTLV Infections

Human T-Cell Lymphotropic Viruses (HTLV) type 1 and type 2 account for an estimated five to 10 million infections worldwide and are transmitted through breast feeding, sexual contacts and contaminated... Read more

Pathology

view channel
Illustration

AI Accurately Detects and Diagnoses Colorectal Cancer from Tissue Scans As Well or Better Than Pathologists

Artificial intelligence (A) can accurately detect and diagnose colorectal cancer from tissue scans as well or better than pathologists, according to a new study. The study, which was conducted by researchers... Read more

Technology

view channel
Image: PKeye Workflow Monitor System (Photo courtesy of PerkinElmer, Inc.)

PerkinElmer’s New Cloud-Based Platform Enables Laboratory Personnel to Remotely Manage Its Instruments in Real-Time

PerkinElmer, Inc. (Waltham, MA; USA) has launched its PKeye Workflow Monitor, a cloud-based platform enabling laboratory personnel to remotely manage and monitor their PerkinElmer instruments and workflows... Read more

Industry

view channel
Illustration

Global Point of Care Diagnostics Market to Top USD 35 Billion by 2027 Due to Rising Diabetic Cases

The global point of care diagnostics market is projected to grow at a CAGR of close to 6% from more than USD 23 billion in 2020 to over USD 35 billion by 2027, driven by an increase in the number of diabetic... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.